All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Listed as ongoing, but also has a completion date | 2006-004476-12 | A randomised open-label study comparing the safety and efficacy of three different combination antiretroviral regimens as initial therapy for HIV infection. | 2011-12-11 | bad-data |
Reported results | 2011-002107-15 | A randomised, open label study to evaluate the efficacy and safety of maraviroc(MVC) as a switch for N(t)RTI or PI/r in HIV1 infected individuals with stable, well controlled plasma HIV RNA while taki... | 2016-04-19 | due-trials |
Reported results | 2015-000178-36 | A phase II, open-label, single arm, multicentre, international trial of sofosbuvir and GS-5816 for people with chronic hepatitis C virus infection and recent injection drug use | 2018-11-28 | due-trials |
Reported results | 2015-004243-39 | A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection (REACT) | 2020-03-23 | due-trials |
Other | 2016-003724-23 | Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial Triple therapie ter preventie van recidief herseninfarct of hersenbloeding na een intracerebrale bloeding | not-yet-due | |
Reported results | 2017-000694-37 | A phase IIIb, open-label, multicentre, international randomised controlled trial of simplified treatment monitoring for 8 weeks glecaprevir (300mg)/pibrentasvir (120mg) in chronic HCV treatment naïve ... | 2018-12-14 | due-trials |